comprehensive -WSS

comprehensive

author：fashion 2025-09-30 14:09:08 - browse：97

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Calls for Trump's election interference trial to be televised part of long debate

hotspot

entertainment

WSS

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Statins may not be needed by millions of people, study suggests

California wildfire smoke linked to 52,000 early deaths, study says

New report analyzes digital physical therapy solutions' effectiveness

California Joshua trees severely burned in massive wildfire

Lifetime voting ban for felony convictions struck down in Mississippi

focus

comprehensive

leisure time

Psychedelics group wrestles with new pharma identity

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

After affirmative action ruling, medical educators look to 'holistic review'

My daughter's legacy lives on through her writing, phage therapy

Continuity nursing helped my family in our darkest PICU moments

The system is set up to fail children with medical complexity

United colonoscopy coverage change 'may cost lives,' doctors say

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

In age of alternative facts, a scholarly course on calling out crap

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

hotspot

Pediatricians' group reaffirms support for gender

5 takeaways from STAT's examination of Zynex Medical

Does Medicare's free annual wellness visit do any good?

'Essentially witchcraft:' A former naturopath takes on the field

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Eat, drink, but be wary — 4 foods that interact with medications

hotspot

entertainment

leisure time

focus